TRZ-8MMAF

N/A

Report date: 2024/07/03 15:54:12

Base Information

Drug NameTRZ-8MMAF
Drug Alias Name1TRZ is conjugated to 8 molecules of monomethyl auristatin F, MMAF (CHO Pharma/TE-Meds)Trastuzumab monomethyl auristatin F conjugate therapeutic (CHO Pharma/TE-Meds)TRZ-8MMAF
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAF payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonistsTubulin polymerisation inhibitors
TargetsReceptor protein-tyrosine kinase erbB-2Tubulin
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCho Pharma IncT-E Meds Inc
China Registration ClassN/A

Develop Information

Active CompaniesT-E Meds Inc
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A